|
|
| Phases of Development | Preclinical | Phase I | Phase II | Approved | Marketed |
|---|
| Autoimmune | 0 | 0 | 1 | 0 | 0 | | Cardiovascular | 1 | 0 | 0 | 0 | 0 | | Hematology | 0 | 0 | 0 | 1 | 1 | | Inflammation | 1 | 0 | 1 | 0 | 0 | | Neurology | 0 | 0 | 1 | 0 | 0 | | Ophthalmic | 0 | 2 | 1 | 0 | 0 | | Renal | 0 | 0 | 1 | 0 | 0 | | Transplant | 0 | 0 | 1 | 0 | 0 |
|
|
Products Targeting Complement 5 (C5)